Macrophage Pathogen Interactions in Regional Cystic Fibrosis Lung Inflammation

Information

  • Research Project
  • 10207764
  • ApplicationId
    10207764
  • Core Project Number
    K24HL150453
  • Full Project Number
    5K24HL150453-02
  • Serial Number
    150453
  • FOA Number
    PA-19-122
  • Sub Project Id
  • Project Start Date
    7/1/2020 - 4 years ago
  • Project End Date
    5/31/2025 - 2 months from now
  • Program Officer Name
    WHITE, MARQUITTA JONISSE
  • Budget Start Date
    6/1/2021 - 3 years ago
  • Budget End Date
    5/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    5/13/2021 - 3 years ago

Macrophage Pathogen Interactions in Regional Cystic Fibrosis Lung Inflammation

ABSTRACT The goal of this K24 is to provide support to allow Dr. Ashare to spend an additional 25% of her time mentoring junior physician scientists in patient-oriented research on inflammatory lung disease. This K24 will provide the opportunity for Dr. Ashare to expand her program in patient- oriented translational research, integrate new physician scientists and PhD scientists into her research program, and allow for additional protected time so she can mentor additional trainees. In addition, with the help of her senior advisory committee, she will also use this time to improve her own mentoring skills. This K24 describes two aims that involve patient-oriented translational research using primary lung macrophages obtained from human subjects. Each Aim will serve as an individual project for a new trainee. Aim1 exploits preliminary findings that macrophages isolated from different regions of the lung are metabolically different and will specifically investigate the impact of increased glycolytic metabolism in upper lobe macrophages on the generation of inflammation. This aim will also determine the role of succinate accumulation in the generation of the macrophage inflammatory response. Based upon our data demonstrating that there are phenotypic and genotypic differences in Pseudomonas aeruginosa isolates from different regions of the CF lung, Aim 2 will test the hypothesis that regional P. aeruginosa isolates differentially stimulate lung macrophage immune responses and exhibit different responses to extracellular succinate. These two independent but complementary aims will allow new trainees to pursue translational patient-oriented research projects that will lead to a greater understanding of host-pathogen interactions in the CF lung.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    K24
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
    101709
  • Indirect Cost Amount
    8137
  • Total Cost
    109846
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    838
  • Ed Inst. Type
  • Funding ICs
    NHLBI:109846\
  • Funding Mechanism
    OTHER RESEARCH-RELATED
  • Study Section
    MPOR
  • Study Section Name
    NHLBI Mentored Patient-Oriented Research Review Committee
  • Organization Name
    DARTMOUTH-HITCHCOCK CLINIC
  • Organization Department
  • Organization DUNS
    150883460
  • Organization City
    LEBANON
  • Organization State
    NH
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    037561000
  • Organization District
    UNITED STATES